Lymphotoxin signaling is initiated by the viral polymerase in HCV-linked tumorigenesis

• Published in: PLoS pathogens 2013-03, Vol.9 (3), p.e1003234-e1003234
• Main Authors: Simonin, Yannick, Vegna, Serena, Akkari, Leila, Grégoire, Damien, Antoine, Etienne, Piette, Jacques, Floc'h, Nicolas, Lassus, Patrice, Yu, Guann-Yi, Rosenberg, Arielle R, Karin, Michael, Durantel, David, Hibner, Urszula
• Format: Article
• Language: English
• Subjects: Adaptive immunology; Animals; Biology; Cancer; Cell Line; Chemokines - metabolism; Chemotaxis, Leukocyte; Health aspects; Hepacivirus - enzymology; Hepacivirus - pathogenicity; Hepatitis; Hepatitis C virus; Hepatocytes - metabolism; Hepatocytes - pathology; Hepatocytes - virology; Host-Pathogen Interactions; Human health and pathology; Humans; Hépatology and Gastroenterology; I-kappa B Kinase - metabolism; Immunity, Innate; Immunology; Infectious diseases; Leukocytes, Mononuclear - metabolism; Leukocytes, Mononuclear - virology; Life Sciences; Liver; Liver - metabolism; Liver - pathology; Liver - virology; Liver cancer; Liver Neoplasms - metabolism; Liver Neoplasms - pathology; Liver Neoplasms - virology; Lymphocyte Activation; Lymphocytes - immunology; Lymphocytes - virology; Lymphotoxin-beta - metabolism; Male; Mice; Mice, Transgenic; Microbiology and Parasitology; NF-kappa B; Physiological aspects; Proteins; RNA-Dependent RNA Polymerase - antagonists & inhibitors; RNA-Dependent RNA Polymerase - metabolism; Rodents; Signal Transduction; Toxins; Tumors; Up-Regulation; Viral Nonstructural Proteins - antagonists & inhibitors; Viral Nonstructural Proteins - metabolism; Viral proteins; Viral Proteins - metabolism; Virology
• ISSN: 1553-7374; 1553-7366; 1553-7374
• DOI: 10.1371/journal.ppat.1003234

Exposure to hepatitis C virus (HCV) typically results in chronic infection that leads to progressive liver disease ranging from mild inflammation to severe fibrosis and cirrhosis as well as primary liver cancer. HCV triggers innate immune signaling within the infected hepatocyte, a first step in mounting of the adaptive response against HCV infection. Persistent inflammation is strongly associated with liver tumorigenesis. The goal of our work was to investigate the initiation of the inflammatory processes triggered by HCV viral proteins in their host cell and their possible link with HCV-related liver cancer. We report a dramatic upregulation of the lymphotoxin signaling pathway and more specifically of lymphotoxin-β in tumors of the FL-N/35 HCV-transgenic mice. Lymphotoxin expression is accompanied by activation of NF-κB, neosynthesis of chemokines and intra-tumoral recruitment of mononuclear cells. Spectacularly, IKKβ inactivation in FL-N/35 mice drastically reduces tumor incidence. Activation of lymphotoxin-β pathway can be reproduced in several cellular models, including the full length replicon and HCV-infected primary human hepatocytes. We have identified NS5B, the HCV RNA dependent RNA polymerase, as the viral protein responsible for this phenotype and shown that pharmacological inhibition of its activity alleviates activation of the pro-inflammatory pathway. These results open new perspectives in understanding the inflammatory mechanisms linked to HCV infection and tumorigenesis.